07 August 2025 : Database Analysis
Trends and Efficacy in Clostridioides difficile Infection Management at a Polish Clinical Hospital
Jarosław Drobnik
ABDEG 1, Piotr Pobrotyn ADEFG 2*, Urszula Grata-Borkowska DF 1, Katarzyna Madziarska DE 3, Mateusz Baran ABCDEF 4
DOI: 10.12659/MSM.948254
Med Sci Monit 2025; 31:e948254
Table 5 Analysis of the length of hospitalization of patients with CDI, depending on the treatment used at the UCHW in 2016–2018.
| The group of patients | Method of treatment | Median | Interquartile range | P |
|---|---|---|---|---|
| 1 | No chemotherapeutic | 18.5 | 16.75 | |
| 2 | Metronidazole only | 18 | 16.75 | |
| 3 | Vancomycin only | 35 | 18.50 | |
| 4 | Metronidazole and vancomycin | 35 | 34.00 | |
| 5 | Rifaximin plus metronidazole and/or vancomycin | 20 | 16.50 | |
| 6 | Fidaxomicin plus vancomycin or fidaxomicin plus vancomycin and metronidazole | 23 | 4.00 | |
| Dunn’s test. Z coefficients are above the main diagonal of the matrix, and the significance levels of individual comparisons are below the main diagonal. | ||||